Compliance with new US FDA informed consent rule nears, guidance available for small device, drug firms

As of 7 March, medical device and drug companies will have to start complying with a new US informed consent rule to notify potential participants in certain trials that information on the trial has been, or will be, included in the publicly accessible databank, www.ClinicalTrials.gov.